Global Flow Cytometry in Oncology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.

According to our (Global Info Research) latest study, the global Flow Cytometry in Oncology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Flow Cytometry in Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Flow Cytometry in Oncology market size and forecasts, in consumption value ($ Million), 2018-2029
Global Flow Cytometry in Oncology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Flow Cytometry in Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Flow Cytometry in Oncology market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Flow Cytometry in Oncology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Flow Cytometry in Oncology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc. and Bio-Rad Laboratories, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Flow Cytometry in Oncology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Assays and Kits
    Instruments
    Reagents and Consumables
    Software

Market segment by Application
    Diagnostic Laboratories
    Hospitals and Healthcare Centers
    Academic and Research Institutions
    Others

Market segment by players, this report covers
    Agilent Technologies, Inc.
    Apogee Flow Systems Ltd.
    Becton, Dickinson and Company
    bioAffinity Technologies, Inc.
    Bio-Rad Laboratories, Inc.
    Bio-Techne Corporation Cytek Biosciences
    Cytognos, S.L.
    Danaher Corporation
    Miltenyi Biotec B.V. and Co. KG
    Laboratory Corporation of America Holdings
    Luminex Corporation
    NeoGenomics Laboratories, Inc.
    Sony Corporation
    Thermo Fisher Scientific Inc

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Flow Cytometry in Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Flow Cytometry in Oncology, with revenue, gross margin and global market share of Flow Cytometry in Oncology from 2018 to 2023.
Chapter 3, the Flow Cytometry in Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Flow Cytometry in Oncology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Flow Cytometry in Oncology.
Chapter 13, to describe Flow Cytometry in Oncology research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Flow Cytometry in Oncology
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Flow Cytometry in Oncology by Type
        1.3.1 Overview: Global Flow Cytometry in Oncology Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Flow Cytometry in Oncology Consumption Value Market Share by Type in 2022
        1.3.3 Assays and Kits
        1.3.4 Instruments
        1.3.5 Reagents and Consumables
        1.3.6 Software
    1.4 Global Flow Cytometry in Oncology Market by Application
        1.4.1 Overview: Global Flow Cytometry in Oncology Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Diagnostic Laboratories
        1.4.3 Hospitals and Healthcare Centers
        1.4.4 Academic and Research Institutions
        1.4.5 Others
    1.5 Global Flow Cytometry in Oncology Market Size & Forecast
    1.6 Global Flow Cytometry in Oncology Market Size and Forecast by Region
        1.6.1 Global Flow Cytometry in Oncology Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Flow Cytometry in Oncology Market Size by Region, (2018-2029)
        1.6.3 North America Flow Cytometry in Oncology Market Size and Prospect (2018-2029)
        1.6.4 Europe Flow Cytometry in Oncology Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Flow Cytometry in Oncology Market Size and Prospect (2018-2029)
        1.6.6 South America Flow Cytometry in Oncology Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Flow Cytometry in Oncology Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Agilent Technologies, Inc.
        2.1.1 Agilent Technologies, Inc. Details
        2.1.2 Agilent Technologies, Inc. Major Business
        2.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Product and Solutions
        2.1.4 Agilent Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
    2.2 Apogee Flow Systems Ltd.
        2.2.1 Apogee Flow Systems Ltd. Details
        2.2.2 Apogee Flow Systems Ltd. Major Business
        2.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product and Solutions
        2.2.4 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Apogee Flow Systems Ltd. Recent Developments and Future Plans
    2.3 Becton, Dickinson and Company
        2.3.1 Becton, Dickinson and Company Details
        2.3.2 Becton, Dickinson and Company Major Business
        2.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Product and Solutions
        2.3.4 Becton, Dickinson and Company Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans
    2.4 bioAffinity Technologies, Inc.
        2.4.1 bioAffinity Technologies, Inc. Details
        2.4.2 bioAffinity Technologies, Inc. Major Business
        2.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product and Solutions
        2.4.4 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 bioAffinity Technologies, Inc. Recent Developments and Future Plans
    2.5 Bio-Rad Laboratories, Inc.
        2.5.1 Bio-Rad Laboratories, Inc. Details
        2.5.2 Bio-Rad Laboratories, Inc. Major Business
        2.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product and Solutions
        2.5.4 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
    2.6 Bio-Techne Corporation Cytek Biosciences
        2.6.1 Bio-Techne Corporation Cytek Biosciences Details
        2.6.2 Bio-Techne Corporation Cytek Biosciences Major Business
        2.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product and Solutions
        2.6.4 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bio-Techne Corporation Cytek Biosciences Recent Developments and Future Plans
    2.7 Cytognos, S.L.
        2.7.1 Cytognos, S.L. Details
        2.7.2 Cytognos, S.L. Major Business
        2.7.3 Cytognos, S.L. Flow Cytometry in Oncology Product and Solutions
        2.7.4 Cytognos, S.L. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Cytognos, S.L. Recent Developments and Future Plans
    2.8 Danaher Corporation
        2.8.1 Danaher Corporation Details
        2.8.2 Danaher Corporation Major Business
        2.8.3 Danaher Corporation Flow Cytometry in Oncology Product and Solutions
        2.8.4 Danaher Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Danaher Corporation Recent Developments and Future Plans
    2.9 Miltenyi Biotec B.V. and Co. KG
        2.9.1 Miltenyi Biotec B.V. and Co. KG Details
        2.9.2 Miltenyi Biotec B.V. and Co. KG Major Business
        2.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product and Solutions
        2.9.4 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Miltenyi Biotec B.V. and Co. KG Recent Developments and Future Plans
    2.10 Laboratory Corporation of America Holdings
        2.10.1 Laboratory Corporation of America Holdings Details
        2.10.2 Laboratory Corporation of America Holdings Major Business
        2.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product and Solutions
        2.10.4 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
    2.11 Luminex Corporation
        2.11.1 Luminex Corporation Details
        2.11.2 Luminex Corporation Major Business
        2.11.3 Luminex Corporation Flow Cytometry in Oncology Product and Solutions
        2.11.4 Luminex Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Luminex Corporation Recent Developments and Future Plans
    2.12 NeoGenomics Laboratories, Inc.
        2.12.1 NeoGenomics Laboratories, Inc. Details
        2.12.2 NeoGenomics Laboratories, Inc. Major Business
        2.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product and Solutions
        2.12.4 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 NeoGenomics Laboratories, Inc. Recent Developments and Future Plans
    2.13 Sony Corporation
        2.13.1 Sony Corporation Details
        2.13.2 Sony Corporation Major Business
        2.13.3 Sony Corporation Flow Cytometry in Oncology Product and Solutions
        2.13.4 Sony Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Sony Corporation Recent Developments and Future Plans
    2.14 Thermo Fisher Scientific Inc
        2.14.1 Thermo Fisher Scientific Inc Details
        2.14.2 Thermo Fisher Scientific Inc Major Business
        2.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product and Solutions
        2.14.4 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Flow Cytometry in Oncology Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Flow Cytometry in Oncology by Company Revenue
        3.2.2 Top 3 Flow Cytometry in Oncology Players Market Share in 2022
        3.2.3 Top 6 Flow Cytometry in Oncology Players Market Share in 2022
    3.3 Flow Cytometry in Oncology Market: Overall Company Footprint Analysis
        3.3.1 Flow Cytometry in Oncology Market: Region Footprint
        3.3.2 Flow Cytometry in Oncology Market: Company Product Type Footprint
        3.3.3 Flow Cytometry in Oncology Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Flow Cytometry in Oncology Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Flow Cytometry in Oncology Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Flow Cytometry in Oncology Consumption Value Market Share by Application (2018-2023)
    5.2 Global Flow Cytometry in Oncology Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Flow Cytometry in Oncology Consumption Value by Type (2018-2029)
    6.2 North America Flow Cytometry in Oncology Consumption Value by Application (2018-2029)
    6.3 North America Flow Cytometry in Oncology Market Size by Country
        6.3.1 North America Flow Cytometry in Oncology Consumption Value by Country (2018-2029)
        6.3.2 United States Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        6.3.3 Canada Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        6.3.4 Mexico Flow Cytometry in Oncology Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Flow Cytometry in Oncology Consumption Value by Type (2018-2029)
    7.2 Europe Flow Cytometry in Oncology Consumption Value by Application (2018-2029)
    7.3 Europe Flow Cytometry in Oncology Market Size by Country
        7.3.1 Europe Flow Cytometry in Oncology Consumption Value by Country (2018-2029)
        7.3.2 Germany Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        7.3.3 France Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        7.3.5 Russia Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        7.3.6 Italy Flow Cytometry in Oncology Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Flow Cytometry in Oncology Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Flow Cytometry in Oncology Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Region
        8.3.1 Asia-Pacific Flow Cytometry in Oncology Consumption Value by Region (2018-2029)
        8.3.2 China Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        8.3.3 Japan Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        8.3.4 South Korea Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        8.3.5 India Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        8.3.7 Australia Flow Cytometry in Oncology Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Flow Cytometry in Oncology Consumption Value by Type (2018-2029)
    9.2 South America Flow Cytometry in Oncology Consumption Value by Application (2018-2029)
    9.3 South America Flow Cytometry in Oncology Market Size by Country
        9.3.1 South America Flow Cytometry in Oncology Consumption Value by Country (2018-2029)
        9.3.2 Brazil Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        9.3.3 Argentina Flow Cytometry in Oncology Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Flow Cytometry in Oncology Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Flow Cytometry in Oncology Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Country
        10.3.1 Middle East & Africa Flow Cytometry in Oncology Consumption Value by Country (2018-2029)
        10.3.2 Turkey Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Flow Cytometry in Oncology Market Size and Forecast (2018-2029)
        10.3.4 UAE Flow Cytometry in Oncology Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Flow Cytometry in Oncology Market Drivers
    11.2 Flow Cytometry in Oncology Market Restraints
    11.3 Flow Cytometry in Oncology Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Flow Cytometry in Oncology Industry Chain
    12.2 Flow Cytometry in Oncology Upstream Analysis
    12.3 Flow Cytometry in Oncology Midstream Analysis
    12.4 Flow Cytometry in Oncology Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Flow Cytometry in Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Flow Cytometry in Oncology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Flow Cytometry in Oncology Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Flow Cytometry in Oncology Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
    Table 6. Agilent Technologies, Inc. Major Business
    Table 7. Agilent Technologies, Inc. Flow Cytometry in Oncology Product and Solutions
    Table 8. Agilent Technologies, Inc. Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Agilent Technologies, Inc. Recent Developments and Future Plans
    Table 10. Apogee Flow Systems Ltd. Company Information, Head Office, and Major Competitors
    Table 11. Apogee Flow Systems Ltd. Major Business
    Table 12. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product and Solutions
    Table 13. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Apogee Flow Systems Ltd. Recent Developments and Future Plans
    Table 15. Becton, Dickinson and Company Company Information, Head Office, and Major Competitors
    Table 16. Becton, Dickinson and Company Major Business
    Table 17. Becton, Dickinson and Company Flow Cytometry in Oncology Product and Solutions
    Table 18. Becton, Dickinson and Company Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Becton, Dickinson and Company Recent Developments and Future Plans
    Table 20. bioAffinity Technologies, Inc. Company Information, Head Office, and Major Competitors
    Table 21. bioAffinity Technologies, Inc. Major Business
    Table 22. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product and Solutions
    Table 23. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. bioAffinity Technologies, Inc. Recent Developments and Future Plans
    Table 25. Bio-Rad Laboratories, Inc. Company Information, Head Office, and Major Competitors
    Table 26. Bio-Rad Laboratories, Inc. Major Business
    Table 27. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product and Solutions
    Table 28. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
    Table 30. Bio-Techne Corporation Cytek Biosciences Company Information, Head Office, and Major Competitors
    Table 31. Bio-Techne Corporation Cytek Biosciences Major Business
    Table 32. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product and Solutions
    Table 33. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Bio-Techne Corporation Cytek Biosciences Recent Developments and Future Plans
    Table 35. Cytognos, S.L. Company Information, Head Office, and Major Competitors
    Table 36. Cytognos, S.L. Major Business
    Table 37. Cytognos, S.L. Flow Cytometry in Oncology Product and Solutions
    Table 38. Cytognos, S.L. Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Cytognos, S.L. Recent Developments and Future Plans
    Table 40. Danaher Corporation Company Information, Head Office, and Major Competitors
    Table 41. Danaher Corporation Major Business
    Table 42. Danaher Corporation Flow Cytometry in Oncology Product and Solutions
    Table 43. Danaher Corporation Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Danaher Corporation Recent Developments and Future Plans
    Table 45. Miltenyi Biotec B.V. and Co. KG Company Information, Head Office, and Major Competitors
    Table 46. Miltenyi Biotec B.V. and Co. KG Major Business
    Table 47. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product and Solutions
    Table 48. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Miltenyi Biotec B.V. and Co. KG Recent Developments and Future Plans
    Table 50. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
    Table 51. Laboratory Corporation of America Holdings Major Business
    Table 52. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product and Solutions
    Table 53. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Laboratory Corporation of America Holdings Recent Developments and Future Plans
    Table 55. Luminex Corporation Company Information, Head Office, and Major Competitors
    Table 56. Luminex Corporation Major Business
    Table 57. Luminex Corporation Flow Cytometry in Oncology Product and Solutions
    Table 58. Luminex Corporation Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Luminex Corporation Recent Developments and Future Plans
    Table 60. NeoGenomics Laboratories, Inc. Company Information, Head Office, and Major Competitors
    Table 61. NeoGenomics Laboratories, Inc. Major Business
    Table 62. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product and Solutions
    Table 63. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. NeoGenomics Laboratories, Inc. Recent Developments and Future Plans
    Table 65. Sony Corporation Company Information, Head Office, and Major Competitors
    Table 66. Sony Corporation Major Business
    Table 67. Sony Corporation Flow Cytometry in Oncology Product and Solutions
    Table 68. Sony Corporation Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Sony Corporation Recent Developments and Future Plans
    Table 70. Thermo Fisher Scientific Inc Company Information, Head Office, and Major Competitors
    Table 71. Thermo Fisher Scientific Inc Major Business
    Table 72. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product and Solutions
    Table 73. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Thermo Fisher Scientific Inc Recent Developments and Future Plans
    Table 75. Global Flow Cytometry in Oncology Revenue (USD Million) by Players (2018-2023)
    Table 76. Global Flow Cytometry in Oncology Revenue Share by Players (2018-2023)
    Table 77. Breakdown of Flow Cytometry in Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Flow Cytometry in Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 79. Head Office of Key Flow Cytometry in Oncology Players
    Table 80. Flow Cytometry in Oncology Market: Company Product Type Footprint
    Table 81. Flow Cytometry in Oncology Market: Company Product Application Footprint
    Table 82. Flow Cytometry in Oncology New Market Entrants and Barriers to Market Entry
    Table 83. Flow Cytometry in Oncology Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Flow Cytometry in Oncology Consumption Value (USD Million) by Type (2018-2023)
    Table 85. Global Flow Cytometry in Oncology Consumption Value Share by Type (2018-2023)
    Table 86. Global Flow Cytometry in Oncology Consumption Value Forecast by Type (2024-2029)
    Table 87. Global Flow Cytometry in Oncology Consumption Value by Application (2018-2023)
    Table 88. Global Flow Cytometry in Oncology Consumption Value Forecast by Application (2024-2029)
    Table 89. North America Flow Cytometry in Oncology Consumption Value by Type (2018-2023) & (USD Million)
    Table 90. North America Flow Cytometry in Oncology Consumption Value by Type (2024-2029) & (USD Million)
    Table 91. North America Flow Cytometry in Oncology Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. North America Flow Cytometry in Oncology Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. North America Flow Cytometry in Oncology Consumption Value by Country (2018-2023) & (USD Million)
    Table 94. North America Flow Cytometry in Oncology Consumption Value by Country (2024-2029) & (USD Million)
    Table 95. Europe Flow Cytometry in Oncology Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Europe Flow Cytometry in Oncology Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Europe Flow Cytometry in Oncology Consumption Value by Application (2018-2023) & (USD Million)
    Table 98. Europe Flow Cytometry in Oncology Consumption Value by Application (2024-2029) & (USD Million)
    Table 99. Europe Flow Cytometry in Oncology Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Flow Cytometry in Oncology Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Flow Cytometry in Oncology Consumption Value by Type (2018-2023) & (USD Million)
    Table 102. Asia-Pacific Flow Cytometry in Oncology Consumption Value by Type (2024-2029) & (USD Million)
    Table 103. Asia-Pacific Flow Cytometry in Oncology Consumption Value by Application (2018-2023) & (USD Million)
    Table 104. Asia-Pacific Flow Cytometry in Oncology Consumption Value by Application (2024-2029) & (USD Million)
    Table 105. Asia-Pacific Flow Cytometry in Oncology Consumption Value by Region (2018-2023) & (USD Million)
    Table 106. Asia-Pacific Flow Cytometry in Oncology Consumption Value by Region (2024-2029) & (USD Million)
    Table 107. South America Flow Cytometry in Oncology Consumption Value by Type (2018-2023) & (USD Million)
    Table 108. South America Flow Cytometry in Oncology Consumption Value by Type (2024-2029) & (USD Million)
    Table 109. South America Flow Cytometry in Oncology Consumption Value by Application (2018-2023) & (USD Million)
    Table 110. South America Flow Cytometry in Oncology Consumption Value by Application (2024-2029) & (USD Million)
    Table 111. South America Flow Cytometry in Oncology Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. South America Flow Cytometry in Oncology Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Middle East & Africa Flow Cytometry in Oncology Consumption Value by Type (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Flow Cytometry in Oncology Consumption Value by Type (2024-2029) & (USD Million)
    Table 115. Middle East & Africa Flow Cytometry in Oncology Consumption Value by Application (2018-2023) & (USD Million)
    Table 116. Middle East & Africa Flow Cytometry in Oncology Consumption Value by Application (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Flow Cytometry in Oncology Consumption Value by Country (2018-2023) & (USD Million)
    Table 118. Middle East & Africa Flow Cytometry in Oncology Consumption Value by Country (2024-2029) & (USD Million)
    Table 119. Flow Cytometry in Oncology Raw Material
    Table 120. Key Suppliers of Flow Cytometry in Oncology Raw Materials
List of Figures
    Figure 1. Flow Cytometry in Oncology Picture
    Figure 2. Global Flow Cytometry in Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Flow Cytometry in Oncology Consumption Value Market Share by Type in 2022
    Figure 4. Assays and Kits
    Figure 5. Instruments
    Figure 6. Reagents and Consumables
    Figure 7. Software
    Figure 8. Global Flow Cytometry in Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Flow Cytometry in Oncology Consumption Value Market Share by Application in 2022
    Figure 10. Diagnostic Laboratories Picture
    Figure 11. Hospitals and Healthcare Centers Picture
    Figure 12. Academic and Research Institutions Picture
    Figure 13. Others Picture
    Figure 14. Global Flow Cytometry in Oncology Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Flow Cytometry in Oncology Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Flow Cytometry in Oncology Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Flow Cytometry in Oncology Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Flow Cytometry in Oncology Consumption Value Market Share by Region in 2022
    Figure 19. North America Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Flow Cytometry in Oncology Revenue Share by Players in 2022
    Figure 25. Flow Cytometry in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Flow Cytometry in Oncology Market Share in 2022
    Figure 27. Global Top 6 Players Flow Cytometry in Oncology Market Share in 2022
    Figure 28. Global Flow Cytometry in Oncology Consumption Value Share by Type (2018-2023)
    Figure 29. Global Flow Cytometry in Oncology Market Share Forecast by Type (2024-2029)
    Figure 30. Global Flow Cytometry in Oncology Consumption Value Share by Application (2018-2023)
    Figure 31. Global Flow Cytometry in Oncology Market Share Forecast by Application (2024-2029)
    Figure 32. North America Flow Cytometry in Oncology Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Flow Cytometry in Oncology Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Flow Cytometry in Oncology Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Flow Cytometry in Oncology Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Flow Cytometry in Oncology Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Flow Cytometry in Oncology Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Flow Cytometry in Oncology Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Flow Cytometry in Oncology Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Flow Cytometry in Oncology Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Flow Cytometry in Oncology Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Flow Cytometry in Oncology Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Flow Cytometry in Oncology Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Flow Cytometry in Oncology Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Flow Cytometry in Oncology Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Flow Cytometry in Oncology Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 66. Flow Cytometry in Oncology Market Drivers
    Figure 67. Flow Cytometry in Oncology Market Restraints
    Figure 68. Flow Cytometry in Oncology Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Flow Cytometry in Oncology in 2022
    Figure 71. Manufacturing Process Analysis of Flow Cytometry in Oncology
    Figure 72. Flow Cytometry in Oncology Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
bioAffinity Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos, S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories, Inc.
Sony Corporation
Thermo Fisher Scientific Inc